People: Antares Pharma Inc (ATRS.PH)
4.05USD
17 May 2013
$0.08 (+2.02%)
$3.97
$4.05
$4.05
$4.02
1,500
--
--
--
Sadowski, Peter
Brief Biography
Dr. Peter Sadowski, Ph.D. is Senior Vice President, Chief Technology Officer of Antares Pharma Inc. He joined the Company in March 1994 as Vice President, Product Development and has been promoted on various occasions since that time. From October 1992 to February 1994, Dr. Sadowski served as Manager, Product Development for GalaGen, Inc., a biopharmaceutical company. From 1988 to 1992, he was Vice President, Research and Development for American Biosystems, Inc., a medical device company. Dr. Sadowski holds a Ph.D. in microbiology from the University of Minnesota.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 378,000 | -- | 51,411 | 467,994 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | 245,388 | 4,592.00 |
| Unexercisable | 40,535 | 9,323.00 |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Leonard Jacob |
-- |
Paul Wotton |
1,166,630 |
Robert Apple |
731,669 |
Kaushik Dave |
683,161 |
Peter Sadowski |
467,994 |
Thomas Garrity |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
